3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Retinoblastoma
11
Unspecified Adult Solid Tumor, Protocol Specific
8
Solid Tumors
4
Wilms Tumor
2
Sarcoma
2
Osteosarcoma
2
Neuroblastoma
2
Unspecified Childhood Solid Tumor, Protocol Specific
1
Testicular Neoplasms
1
Testicular Germ Cell Tumor
1
Solid Tumours
1
Solid Tumor
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinal Neoplasms
1
Recurrence
1
Pediatric Brain Tumor
1
Ovarian Neoplasms
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasms, Germ Cell and Embryonal
1
Malignant Solid Tumors
1
Lymphoma
1
Liver Neoplasms
1
Kidney Neoplasms
1
Hepatoblastoma
1
Head and Neck Neoplasms
1
Fibrosarcoma
1
Eye Neoplasms
1
Interventions
Granulocyte Colony-Stimulating Factor
2
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
etoposide phosphate
1
Ursodeoxycholic Acid
1
Topotecan
1
Thiotepa
1
Sirolimus
1
Simvastatin
1
Radiation
1
Plicamycin
1
Paclitaxel
1
Mesna
1
Melphalan
1
Leukapheresis
1
Ifosfamide
1
Etoposide
1
Cyclophosphamide
1
Carboplatin
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Germ Cell and Embryonal
×
Topotecan
×
Other solid neoplasm
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled